BIOCRYST PHARMACEUTICALS INC Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Biocryst Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Biocryst Pharmaceuticals Inc Return On Equity for the quarter ending September 30, 2024 was 26.4 %, a 60.3% decline year-over-year.
  • Biocryst Pharmaceuticals Inc annual Return On Equity for 2023 was 57.2 %, a 47% decline from 2022.
  • Biocryst Pharmaceuticals Inc annual Return On Equity for 2022 was 108 %, a 36.1% decline from 2021.
  • Biocryst Pharmaceuticals Inc annual Return On Equity for 2021 was 169 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 57.2 -50.8 -47% Jan 1, 2023 Dec 31, 2023
2022 108 -61.2 -36.1% Jan 1, 2022 Dec 31, 2022
2021 169 +943 Jan 1, 2021 Dec 31, 2021
2020 -774 +3.45K +81.7% Jan 1, 2020 Dec 31, 2020
2019 -4.22K -4.05K -2302% Jan 1, 2019 Dec 31, 2019
2018 -176 -69.3 -65.1% Jan 1, 2018 Dec 31, 2018
2017 -107 +365 +77.4% Jan 1, 2017 Dec 31, 2017
2016 -472 -404 -592% Jan 1, 2016 Dec 31, 2016
2015 -68.2 +6.02 +8.11% Jan 1, 2015 Dec 31, 2015
2014 -74.3 -1.33K -106% Jan 1, 2014 Dec 31, 2014
2013 1.25K +1.58K Jan 1, 2013 Dec 31, 2013
2012 -325 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.